Kwality Pharmaceuticals: our biggest position in portfolio, the best quarter in its history, and a Big Four auditor to sign the next one
We have been buying this share in instalments, adding on upward moves and on reasonable corrections. We now hold 653 shares at an average cost of ₹2,482.78 which represents 11.9% of our total model portfolio
Kwality Pharmaceuticals reported its September quarter on 12 November. Revenue rose 63% on the year. Profit rose 106%. The operating margin was the highest the company has ever reported. The company raised its own forecast…
Continue reading with Empirica
This full article is available to Empirica subscribers. Unlock it — and all our research & portfolios — with a plan.